ASX-Dividend-Report-Banner

Human Frontier Science Program: Research Grants Awarded to 104 of the Most Pioneering Scientists from 30 Nations

April 02, 2025 11:10 AM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 Human Frontier Science Program: Research Grants Awarded to 104 of the Most Pioneering Scientists from 30 Nations
Image source: Kalkine Media

STRASBOURG, France, April 2, 2025 /PRNewswire/ -- To pioneer new frontiers in life science research, the Human Frontier Science Program has awarded 104 of the world's most ingenious scientists from 30 nations with 2025 HFSP Research Grants and the first round of the new Accelerator Grants. 

Human Frontier Science Program: Research Grants Awarded to 104 of the Most Pioneering Scientists from 30 Nations
Human Frontier Science Program: Research Grants Awarded to 104 of the Most Pioneering Scientists from 30 Nations

"Our awards provide the world's top scientists with the means to explore new frontiers in scientific research and discover whole new worlds of possibility," said Pavel Kabat, HFSP Secretary-General.

Scientists from these nations receive 2025 HFSP Research Grants & Accelerator Awards:

Australia

China

Hungary

Norway

Spain

Belgium

Czech Republic

India

Netherlands

Sweden

Brazil

Denmark

Israel

New Zealand

Switzerland

Burkina Faso

France

Italy

Portugal

Turkey

Canada

Germany

Japan

Singapore

United Kingdom

Chile

Greece

Korea

South Africa

United States of America

In 2025, HFSP awarded 30 Research Grants and 12 Accelerator Grants that span the full range of life science research. Highlights include:

  • New insight on epigenetics, the study of how our environment influences our genes by changing the chemicals that attach to them. This project resumes research began more than 100 years ago at the Biologische Versuchsanstalt (BVA) in Vienna, Austria.
  • Research on how tick-borne diseases are being spread over great distances, including by migratory birds, and becoming a global concern. The study analyzes rapidly changing environmental factors driven by climate change that affect tick populations, and, thus, the spread of viral diseases.

HFSPO reviewed proposals from over 2,100 researchers for 780 projects. To read the awardees' abstracts, click: 2025 HFSP Research Grant Awardees. To find individual scientists, search the Index by Country.

About HFSP Awards:

HFSP Research Grants: last for three years and on average, provide $400,000 USD per year. Both early career scientists and those at any stage of their career may apply.

HFSP Accelerator Awards: This new program seeks to strengthen the world's life science enterprise by diversifying the pool of expertise by including scientists on groundbreaking research grant teams, who might not otherwise have comparable opportunities. Accelerator awards go to scientists who work at research institutions in these HFSP Member countries: India, Japan, New Zealand, Norway, Korea, Singapore, and South Africa.

Journalists can view the full press release here.

For more information or to schedule interviews, contact Rachael Bishop, Science Writer and Editor: phone: +33 (0)7 81 87 62 21 or email: [email protected].


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.